- Home
- NFGC vs STAA Comparison
NFGC vs STAA Comparison
Compare NFGC & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NFGC | STAA |
|---|---|---|
| Founded | 2016 | 1982 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Ophthalmic Goods |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 928.8M | 867.9M |
| IPO Year | 2021 | 1995 |
Fundamental Metrics
Financial Performance| Metric | NFGC | STAA |
|---|---|---|
| Price | $2.18 | $26.84 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $22.81 |
| AVG Volume (30 Days) | ★ 1.7M | 1.1M |
| Earning Date | 05-11-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $239,442,000.00 |
| Revenue This Year | $3,542.00 | $30.82 |
| Revenue Next Year | $118.57 | $8.41 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.19 | $15.59 |
| 52 Week High | $3.59 | $30.81 |
Technical Indicators
Market Signals| Indicator | NFGC | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 54.37 | 61.78 |
| Support Level | $1.85 | $26.54 |
| Resistance Level | $2.34 | $27.27 |
| Average True Range (ATR) | 0.12 | 1.07 |
| MACD | 0.02 | -0.10 |
| Stochastic Oscillator | 67.78 | 63.16 |
Price Performance
Historical ComparisonAbout NFGC New Found Gold Corp
New Found Gold Corp is a mineral exploration company engaged in the acquisition, exploration and evaluation of resource properties with a focus on gold properties located in the Provinces of Newfoundland and Labrador and Ontario, Canada. The Company's exploration is focused on discovering and delineating gold resources. The Company has one material property: the Queensway Project located in Newfoundland, Canada (the Queensway Project).
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.